Zacks Investment Research downgraded shares of SUNSHINE HEART (SSH) from N/A to NEUTRAL on November 20, 2012, with a target price of $6.90.
Sunshine Heart, Inc. is a medical device company engaged in the commercialization of the C-Pulse Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure. Sunshine Heart, Inc. is headquartered in Minneapolis.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on SUNSHINE HEART (SSH),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment